Phase II study of weekly amrubicin in patients with refractory or relapsed non-small cell lung cancer.
Latest Information Update: 26 Aug 2015
At a glance
- Drugs Amrubicin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 02 Oct 2009 New trial record